Samumed And United Therapeutics Announce North American License Agreement For Samumed’s IPF…
Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation for North American rights to Samumed's SM04646, being developed for the treatment of…
Read More...
Read More...
